EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deceleration Capacity as a Marker of Autonomic Cardiac Modulation in Prodromal and Manifest Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy

Elisabeth Ruppert iD, Nuria Mix, Karl Kesper, Axel Bauer, David Vadasz, Vincent Ries, Elisabeth Sittig, Ulrich Koehler, Annette Janzen, Wolfgang H Oertel

European Journal of Neurology · 2025

DOI: 10.1111/ene.70395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Elisabeth Ruppert und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Philipps University of Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Multiple System Atrophy, Supranuclear Palsy, Progressive, Parkinson Disease, Heart Rate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Degenerative parkinsonian syndromes, including the alpha‐synucleinopathies ( aSYN ) Parkinson's disease ( PD ), and multiple system atrophy ( MSA ), and the tauopathy progressive supranuclear palsy ( PSP ), are characterized by motor and non‐motor symptoms. The later subsume autonomic dysfunction, which may appear early or progress with the disease. Cardiac dysfunction varies by syndrome and can also occur in isolated REM sleep behavior disorder ( iRBD ), a prodromal stage of aSYN . Overlapping motor features make early differentiation challenging. Heart rate variability ( HRV ) analysis is a noninvasive tool for evaluating cardiac autonomic function, with deceleration capacity ( DC ) as a sensitive parasympathetic marker. This study compares HRV and DC across parkinsonian syndromes to assess their potential in early diagnosis and differentiation.

Methods

Using standardized 30‐min resting ECG recordings in the early morning, we analyzed HRV parameters in five groups: iRBD ( n = 10), PD ( n = 10), MSA ( n = 10), PSP ( n = 9), and healthy controls ( HC , n = 10). Evaluated HRV parameters included HRV index ( HRVI ), reflecting overall variability, and DC.

Results

As expected, DC was significantly lower in MSA (3.82 ± 1.38) and unexpectedly even lower in PSP (3.19 ± 2.77), compared to HC (9.66 ± 4.67) and PD (7.55 ± 2.48). These findings are novel for PSP . HRVI was significantly reduced in PSP , while other HRV parameters showed no significant differences.

Conclusions

Deceleration capacity (DC) reduction in MSA and PSP suggests pronounced cardiac parasympathetic dysfunction. DC may support differentiation between PD and atypical syndromes, but larger studies are needed for validation. Given the impact of autonomic dysfunction on quality of life and mortality, comprehensive autonomic testing should be included in the diagnostic workup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple System AtrophySupranuclear Palsy, ProgressiveParkinson DiseaseHeart RateAutonomic Nervous SystemAutonomic Nervous System DiseasesHumansMaleAgedFemaleMiddle AgedElectrocardiographyProdromal SymptomsREM Sleep Behavior Disorder

Stichwörter der Autor:innen

Parkinsons diseaseatypical parkinsonian syndromesdeceleration capacityheart rate variabilityisolated REM sleep behavior disorder

Autor:innen und Institutionen

  • Department of Neurology, Philipps University of Marburg, Marburg, Germany.
  • Department of Neurology, CIRCSom (International Research Center for ChronoSomnology) & Sleep Disorders Center, University Hospital of Strasbourg, University of Strasbourg, Paris, France.
  • Department of Pulmonology, University of Marburg, Marburg, Germany.
  • Department of Cardiology and Angiology, Clinic of Internal Medicine, University Hospital Innsbruck, Innsbruck, Austria.

ORCID-Profile: Elisabeth Ruppert

Zitieren

APA

Ruppert, E., Mix, N., Kesper, K., Bauer, A., Vadasz, D., Ries, V., Sittig, E., Koehler, U., Janzen, A., & Oertel, W. H. (2025). Deceleration Capacity as a Marker of Autonomic Cardiac Modulation in Prodromal and Manifest Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy. European Journal of Neurology. https://doi.org/10.1111/ene.70395

Vancouver

Ruppert E, Mix N, Kesper K, Bauer A, Vadasz D, Ries V, et al. Deceleration Capacity as a Marker of Autonomic Cardiac Modulation in Prodromal and Manifest Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy. European Journal of Neurology. 2025. doi:10.1111/ene.70395

BibTeX
@article{Ruppert2025,
  author = {Ruppert, Elisabeth and Mix, Nuria and Kesper, Karl and Bauer, Axel and Vadasz, David and Ries, Vincent and Sittig, Elisabeth and Koehler, Ulrich and Janzen, Annette and Oertel, Wolfgang H},
  title = {Deceleration Capacity as a Marker of Autonomic Cardiac Modulation in Prodromal and Manifest Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70395}
}
Kostenlos starten →